Breaking News, Collaborations & Alliances

Vector BioPharma Enters Collaboration with iBET

Will develop high-throughput analytical methods and scalable processes for gene delivery.

Author Image

By: Charlie Sternberg

Associate Editor

Vector BioPharma AG, a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, has entered into a strategic, multi-phase collaboration with the Instituto de Biologia Experimental e Tecnológica (iBET), a research-intensive organization specialized in biotechnology research and bioprocess development.   The partnership aims to develop high-throughput quantification methods to advance the technical development of Vec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters